BillionaireNet
Lei
Jin Lei
Rank #2682
CHINAHealthcarePharmaceuticals

Jin Lei

Net Worth
$1.306B
+0.02% (24h)
Jin Lei, a prominent figure in the healthcare sector, is the CEO of GenSci Pharmaceutical. With a current estimated net worth of $1.3 Billion, Jin Lei's wealth stems primarily from his ventures in the pharmaceuticals industry. His career began after he received a Master's degree from the Chinese Academy of Sciences and a Ph.D. from the University of California. He worked for biomedical firm Genentech in the U.S. and then returned to China in 1995, co-founding GeneScience Pharmaceuticals in 1996. His achievements have been recognized through various awards. As of 2024, he holds the global rank of 2661 in the list of billionaires.

The Full Dossier

Early Life

Information regarding Jin Lei's early life is limited, but his educational background reveals a strong foundation in science. He holds a Master's degree from the Chinese Academy of Sciences and a Ph.D. from the University of California, indicating a focus on scientific and medical fields. Following his doctoral studies, he gained experience in the United States, working for the biomedical firm Genentech.

Rise to Success

Jin Lei's career took a pivotal turn when he returned to China in 1995. He co-founded GeneScience Pharmaceuticals in 1996, with funding from Changchun High and New Tech. This venture marked the beginning of his entrepreneurial journey in the pharmaceutical industry. GenSci Pharmaceutical, under his leadership, became a manufacturer of recombinant human growth hormone.

Key Business Strategies

The exact key business strategies employed by Jin Lei are not explicitly detailed in the available sources, but the success of GenSci Pharmaceutical suggests a focus on the development and manufacturing of specialized medical products, specifically recombinant human growth hormone. The company went public by merging with Shenzhen-listed Changchun High & New Technology Industries Group in 2019.

Philanthropy

There is no specific information available about Jin Lei's philanthropy initiatives.

Career Timeline

2019

GenSci went public

GenSci went public by merging with Shenzhen-listed Changchun High & New Technology Industries Group.

1996

Co-founded GeneScience Pharmaceuticals

Co-founded GeneScience Pharmaceuticals with funding from Changchun High and New Tech.

1995

Returned to China

Returned to China after working in the United States.

Wealth Trajectory